Terbutaline
From Wikipedia, the free encyclopedia
 |
|
|
Terbutaline
|
|
| Systematic (IUPAC) name | |
| 5-(1-hydroxy-2-tert-butylamino-ethyl)benzene-1,3-diol | |
| Identifiers | |
| CAS number | |
| ATC code | R03 R03CC03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C12H19NO3 |
| Mol. mass | 225.284 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | GI tract (oral), liver; CYP450: unknown |
| Half life | urine 90% (60% unchanged), bile/faeces; Half-life: 3-4h |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
B |
| Legal status | |
| Routes | SQ, Oral, Inhaled |
The drug Terbutaline (trade names Brethine, Bricanyl, or Brethaire) is a β2-adrenergic receptor agonist, used as a fast-acting bronchodilator (often used as a short-term asthma treatment) and as a tocolytic to delay premature labour. The inhaled form of terbutaline starts working within 15 minutes and can last up to 6 hours.
Terbutaline as a treatment for premature labour is an off-label use not approved by the FDA. Studies have suggested that terbutaline is a developmental neurotoxicant and may cause brain damage to the infant. (J Pharmacol Exp Ther. 2004 Feb;308(2):529-37. Epub 2003 Nov 10.)
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|
|
|---|---|
| Anticholinergics | Ipratropium, Tiotropium |
| Short acting β2-agonists | Salbutamol, Terbutaline |
| Long acting β2-agonists (LABA) | Bambuterol, Clenbuterol, Fenoterol, Formoterol, Salmeterol |
| Corticosteroids | Beclometasone, Budesonide, Ciclesonide, Fluticasone |
| Leukotriene antagonists | Montelukast, Pranlukast, Zafirlukast |
| Xanthines | Aminophylline, Theobromine, Theophylline |
| Mast cell stabilizers | Cromoglicate, Nedocromil |
| Combination products | Budesonide/formoterol, Fluticasone/salmeterol, Ipratropium/salbutamol |
